#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
proLékaře.cz / Journals / Forum Diabetologicum / 2022 - Supplementum 1

Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)

Download PDF

Published in: Forum Diab 2022; 11(Supplementum 1): 23-55
Category:

Labels
Diabetology Endocrinology Internal medicine
Projekt SIMPLIFY: Prechod na liečbu fixnou kombináciou inzulínu degludek a agonistu GLP1-receptorov liraglutid (IDegLira) po predchádzajúcej intenzifikovanej liečbe inzulínom (IIT)
Rationalisation of previous multiple insulin treatment by switching to a fixed combination of basal insulin degludec and the GLP1-receptor agonist liraglutide (IDegLira): results of the SIMPLIFY study after 14 weeks
Simplification of previous multiple insulin treatment by switching to a fixed combination of basal insulin degludec and GLP1-receptor agonist liraglutide: SIMPLIFY study Evaluation of the early outcome questionnaires
Article was published in

Forum Diabetologicum

Issue Supplementum 1
2022 Issue Supplementum 1
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#